Advicenne raises $17.2 mln

Advicenne said March 20 that it closed a 16 million euro ($17.2 million) financing round led by IRDI SORIDEC Gestion, Cemag Invest and MI Care. Also participating were existing investors InnoBio (Bpifrance) and IXO Private Equity together with private individuals. Advicenne, of Nimes, France, a late-stage biopharmaceutical company focused on the development of paediatric friendly therapeutics for the treatment of orphan renal and neurological diseases.

20 March 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail